Xoma | XOMA - Cost Of Sales

Stock Price
25.81
Daily Change
1.41 5.78%
Monthly
-5.35%
Yearly
9.74%
Q1 Forecast
25.01

Xoma reported 116K in Cost of Sales for its fiscal quarter ending in June of 2024.





Cost Of Sales Change Date
AbbVie USD 4.55B 757M Dec/2025
Agenus USD 137K 19K Mar/2025
Agios Pharmaceuticals USD 1.88M 199K Dec/2025
Ardelyx USD 3.98M 10.84M Sep/2025
aTyr Pharma USD 22.13M 6.75M Sep/2025
BioMarin Pharmaceutical USD 144.93M 10M Sep/2025
Celldex Therapeutics USD 54.2M 8.94M Jun/2025
Curis USD 10.27M 610K Jun/2024
Eli Lilly USD 3.37B 363.7M Dec/2025
Emergent BioSolutions USD 381.2M 226.1M Jun/2023
Incyte USD 121.18M 22.18M Dec/2025
MacroGenics USD 44.3M 5.4M Sep/2025
Novartis USD 3.54B 217M Sep/2025
Novartis USD 3.54B 216M Sep/2025
Pfizer USD 6.29B 2.12B Dec/2025
Prothena USD 28.94M 11.58M Sep/2025
Regeneron Pharmaceuticals USD 584.6M 63M Dec/2025
Xoma 116K 112.7K Jun/2024